Kolexia
Rochigneux Philippe Oncologie médicale
Rochigneux Philippe
Oncologie médicale
Centre Paoli-Calmettes
Marseille, France
144 Activités
74 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du poumon Carcinomes Carcinome pulmonaire non à petites cellules Métastase tumorale Néphrocarcinome Carcinome pulmonaire à petites cellules Tumeurs du sein Carcinome hépatocellulaire Tumeurs du cerveau

Collaborateurs

Voir plus
Olive Daniel
Olive Daniel
Centre Paoli-Calmettes, Marseille, France
Chanez Brice
Chanez Brice
Centre Paoli-Calmettes, Marseille, France
Goncalves Anthony
Goncalves Anthony
Centre Paoli-Calmettes, Marseille, France
Ulusakarya Ayhan
Ulusakarya Ayhan
Hôpital Paul Brousse, Villejuif, France

Industries

Voir plus
B3TSI
184 collaboration(s)
Dernière en 2023
M3 Global Research Ltd
82 collaboration(s)
Dernière en 2023
IQVIA
26 collaboration(s)
Dernière en 2022
A+A
10 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
A Platform Study of Novel Immunotherapy Combinations in Participants With Previously Untreated, Advanced/Metastatic Non-Small-Cell Lung Cancer: A Phase 2, Randomized, Open-label, Platform Study Utilizing a Master Protocol to Evaluate Novel Immunotherapy Combinations in Participants With Previously Untreated, Locally Advanced/Metastatic, Programmed Death Ligand 1-Selected Non-Small-Cell Lung Cancer
Essai Clinique (GSK)   20 février 2024
Management and outcomes of brain metastases from pancreatic adenocarcinoma: a pooled analysis and literature review.
Frontiers in oncology   08 janvier 2024
21P Mass cytometry reveals a population of exhausted CD8+ T cells associated with durvalumab/tremelimumab/vinorelbine efficacy in advanced cervical cancer (iMOVIE)
Abstract Book of the ESMO Immuno-Oncology Congress 2023 6-8 December 2023   01 décembre 2023
AGADIR: Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors
Essai Clinique (Institut Bergonié)   27 septembre 2023
CD25high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer.
Cancer research   18 septembre 2023
Dysthyroidism during immune checkpoint inhibitors is associated with improved overall survival in adult cancers: data mining of 1385 electronic patient records.
Journal for immunotherapy of cancer   07 août 2023
Abstract 3239: Selective depletion of regulatory T cells by ALD2510, a novel IL-2-sparing anti-CD25 antibody, synergizes with PD-1 blockade in breast and gynecologic cancers
Proceedings: AACR Annual Meeting 2023   01 avril 2023
RET-MAP: An International Multicenter Study on Clinicobiologic Features and Treatment Response in Patients With Lung Cancer Harboring a RET Fusion.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer   13 janvier 2023
Mass Cytometry Reveals Classical Monocytes, NK Cells, and ICOS+ CD4+ T Cells Associated with Pembrolizumab Efficacy in Patients with Lung Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research   02 décembre 2022
Immune biology of NSCLC revealed by single-cell technologies: implications for the development of biomarkers in patients treated with immunotherapy.
Seminars in immunopathology   21 novembre 2022